Literature DB >> 19429638

Is bicaval orthotopic heart transplantation superior to the biatrial technique?

Samuel Jacob1, Frank Sellke.   

Abstract

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether the bicaval heart transplantation technique is superior to biatrial orthotopic heart transplantation (OHT). Altogether, 175 papers were found using the reported search, of which 20 presented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. We conclude that many papers have documented the superiority of the bicaval technique over the biatrial technique for short-term outcomes. A meta-analysis of 41 papers on this topic found significant benefits for early atrial pressure, tricuspid valve regurgitation, return to sinus rhythm and even perioperative mortality. But for longer-term outcome, the largest series of 11,931 patients found no difference in survival between the two groups and the meta-analysis found no mortality differences at 1 or 3 years. The bicaval technique is also more demanding technically and has a slightly longer bypass and ischaemic time. The United Network for Organ Sharing (UNOS) database showed that in 2005 in the USA the bicaval technique has now become more popular than the biatrial technique (1083 procedures vs. 806).

Entities:  

Mesh:

Year:  2009        PMID: 19429638     DOI: 10.1510/icvts.2008.200121

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  8 in total

1.  Bicaval versus standard technique in orthotopic heart transplant: assessment of atrial performance at magnetic resonance and transthoracic echocardiography.

Authors:  Angelo Maria Dell'Aquila; Stefano Mastrobuoni; Gorka Bastarrika; Beltran Levy Praschker; Pedro Azcárate Agüero; Sara Castaño; Jesus Herreros; Gregorio Rabago
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-04

2.  Tricuspid valve regurgitation after heart transplantation.

Authors:  Murray H Kwon; Richard J Shemin
Journal:  Ann Cardiothorac Surg       Date:  2017-05

Review 3.  Heart transplantation: challenges facing the field.

Authors:  Makoto Tonsho; Sebastian Michel; Zain Ahmed; Alessandro Alessandrini; Joren C Madsen
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-01       Impact factor: 6.915

Review 4.  Heart transplantation in Japan: a critical appraisal for the results and future prospects.

Authors:  Soichiro Kitamura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-08-17

5.  A patient with giant left atrium undergoes orthotopic heart transplantation.

Authors:  Sergey Y Boldyrev; Murat K Lepshokov; Igor I Yakuba; Kirill O Barbukhatty; Vladimir A Porhanov
Journal:  Tex Heart Inst J       Date:  2014-02

6.  Changes in patient characteristics following cardiac transplantation: the Montreal Heart Institute experience.

Authors:  Nicola Vistarini; Anthony Nguyen; Michel White; Normand Racine; Louis P Perrault; Anique Ducharme; Denis Bouchard; Philippe Demers; Michel Pellerin; Yoan Lamarche; Ismaïl El-Hamamsy; Geneviève Giraldeau; Guy Pelletier; Michel Carrier
Journal:  Can J Surg       Date:  2017-09       Impact factor: 2.089

7.  Risk factors associated with post-transplant superior caval vein stenosis in paediatric heart transplantation.

Authors:  Hanna J Tadros; Joseph T Whelihan; Dalia Lopez-Colon; James C Fudge; Himesh V Vyas; Fredrick J Fricker; Biagio A Pietra; Mark S Bleiweis; Dipankar Gupta
Journal:  Cardiol Young       Date:  2021-02-24       Impact factor: 1.023

8.  Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality.

Authors:  Rasmus Rivinius; Matthias Helmschrott; Arjang Ruhparwar; Ann-Kathrin Rahm; Fabrice F Darche; Dierk Thomas; Tom Bruckner; Philipp Ehlermann; Hugo A Katus; Andreas O Doesch
Journal:  Ther Clin Risk Manag       Date:  2017-10-13       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.